Purchase Order 75N95025P00294

Award Date 7/1/25
Potential Completion Date 12/31/25
Potential Value $280K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Baltimore, MD 21218, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,036,522.37 definitive cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The Johns Hopkins University to provide clinical services and resources for NIDA's Intramural Research Program (IRP) in Baltimore, Maryland. The contract has a base period of six months and nine six-month option periods, running through June 2025. The contract was awarded on July 1, 2020 and does not have a set-aside...
This is a federal contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to The Johns Hopkins University. The contract has a ceiling value of $109,658.00 and is a definitive, cost-no-fee contract with a period of performance ending on June 30, 2017. The contract does not have a set-aside designation. The Johns Hopkins University, a private research university located in Baltimore, Maryland, is the prime contractor for...
This is a $598,725.92 cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Johns Hopkins Bayview Medical Center, Inc., a non-profit hospital located in Baltimore, Maryland. The contract is for clinical services and resources in support of NIDA's Intramural Research Program (IRP), with a period of performance from July 1, 2019 to June 30, 2020. The contract was not set aside for any specific business category. Johns Hopkins Bayview Medical...
This is a $114,800 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The Johns Hopkins University, a private research university in Baltimore, MD. The contract has an ultimate completion date of September 29, 2016 and was awarded on September 28, 2015. This contract was not set aside for any specific business type. The Johns Hopkins University has a strong track record of providing research,...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $103,007.40 firm fixed price purchase order contract to The Johns Hopkins University, a private non-profit university located in Baltimore, Maryland. The contract has no set-aside designation and was awarded on September 7, 2018 with a completion date of January 10, 2020. As a leading research institution, The Johns Hopkins University has a history of providing the U.S. government...
The federal contract HHSN271201400042C, awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Johns Hopkins Bayview Medical Center, Inc. (Johns Hopkins Bayview) is for the provision of CLINICAL SUPPORT SERVICES AND RESOURCES. This is a Cost Plus Fixed Fee definitive contract with a potential value of $5,027,325.87 and a period of performance from July 29, 2014 to June 30, 2019. The contract was not set aside for any...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIH NIDA) awarded a Time and Materials contract valued at $270,000.00 to The Johns Hopkins University, a private non-profit research university, to provide custom radiosynthesis of positron emission tomography (PET) ligands and access to a small animal PET scanner. This one-year contract supports the NIH NIDA Neuroimaging Research Branch's research into molecular processes in the living...
This is a $1,292,528.45 cost-no-fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to The Johns Hopkins University. The contract is for the NIH Pain Consortium - Centers of Excellence in Pain Education program, which aims to enhance pain management education for health care professionals. The contract has a period of performance from September 15, 2015 to September 14, 2019, with a one-year base period and several...
This is a definitive cost-no-fee contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The Johns Hopkins University to conduct testing of pharmacological interventions on rhesus monkeys. The $93,307.00 contract has a period of performance through March 31, 2015. The contract does not have a set-aside designation. As a leading research university, The Johns Hopkins University has a long history of supporting federal agencies...
The National Institutes of Health's National Institute on Drug Abuse awarded a $32,720 purchase order to The Johns Hopkins University for gene sequencing and profiling of sample tissue. This firm fixed price contract supports the NIH/NIDA's biomedical research efforts through Johns Hopkins' delivery of genomic analysis services. No subcontractors or set aside designations were identified. The one year period of performance begins in July 2023, with work conducted at Johns Hopkins' Bethesda,...

This federal contract award is for $279,956.00 to provide clinical services and resources for the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) from July 1, 2025 to December 31, 2025. The contract was awarded to The Johns Hopkins University, a private, non-profit research university in Baltimore, Maryland. The contract does not utilize any set-aside designations.

The contract will support NIDA's mission to conduct research on the basic mechanisms of drug use and addiction, evaluate potential addiction therapies, and investigate the long-term impacts of drugs on the human brain and organ systems. The scope includes managing personnel, providing medical consultations, diagnostic testing, specialized nursing services, and accommodations for approximately 500 research participants annually. This contract is part of NIDA's larger research initiatives focused on understanding substance use disorders and developing new treatment methods.

Generated 7/1/25, 2:31 PM